{"cdcTestId":"2013-0350","testcaseName":"Dose 1 to 2 at 8 weeks - 3 days (#1 at \u003E=1 year)","vaccineGroup":"HIB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-08-27T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-08-27T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hib (PRP-OMP)","cvx":"49","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-08-27T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hib (PRP-OMP)","cvx":"49","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-27T15:57:26.691","generalDescription":"This test case describes when a child greater than 12 months of age is administered a second dose of the Hib vaccine at an interval of 8 weeks - 3 days from the first dose that the dose is valid.  No further doses should be forecast.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}